According to this latest study, the 2020 growth of Mesalazine will have significant change from previous year. By the most conservative estimates of global Mesalazine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 131.7 million in 2019. Over the next five years the Mesalazine market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 155.8 million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesalazine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Purity ≥ 97 %
Purity ≥ 98 %
Purity ≥ 99 %
According to the type, purity ≥ 98% is the highest, reaching 48.44% in 2019.
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Mesalazine Tablets
Mesalazine Capsules
Others
Mesalazine tablets has the highest market share in terms of application, at 50.61% in 2019.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
PharmaZell
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mesalazine Consumption 2016-2026
2.1.2 Mesalazine Consumption CAGR by Region
2.2 Mesalazine Segment by Type
2.2.1 Purity ≥ 97 %
2.2.2 Purity ≥ 98 %
2.2.3 Purity ≥ 99 %
2.3 Mesalazine Sales by Type
2.3.1 Global Mesalazine Sales Market Share by Type (2016-2021)
2.3.2 Global Mesalazine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Mesalazine Sale Price by Type (2016-2021)
2.4 Mesalazine Segment by Application
2.4.1 Mesalazine Tablets
2.4.2 Mesalazine Capsules
2.4.3 Others
2.5 Mesalazine Sales by Application
2.5.1 Global Mesalazine Sale Market Share by Application (2016-2021)
2.5.2 Global Mesalazine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Mesalazine Sale Price by Application (2016-2021)
3 Global Mesalazine by Company
3.1 Global Mesalazine Sales Market Share by Company
3.1.1 Global Mesalazine Sales by Company (2019-2021)
3.1.2 Global Mesalazine Sales Market Share by Company (2019-2021)
3.2 Global Mesalazine Revenue Market Share by Company
3.2.1 Global Mesalazine Revenue by Company (2019-2021)
3.2.2 Global Mesalazine Revenue Market Share by Company (2019-2021)
3.3 Global Mesalazine Sale Price by Company
3.4 Global Manufacturers Mesalazine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesalazine Product Location Distribution
3.4.2 Players Mesalazine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Mesalazine by Region
4.1 Global Mesalazine by Region
4.1.1 Global Mesalazine Sales by Region
4.1.2 Global Mesalazine Revenue by Region
4.2 Americas Mesalazine Sales Growth
4.3 APAC Mesalazine Sales Growth
4.4 Europe Mesalazine Sales Growth
4.5 Middle East & Africa Mesalazine Sales Growth
5 Americas
5.1 Americas Mesalazine Sales by Country
5.1.1 Americas Mesalazine Sales by Country (2016-2021)
5.1.2 Americas Mesalazine Revenue by Country (2016-2021)
5.2 Americas Mesalazine Sales by Type
5.3 Americas Mesalazine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesalazine Sales by Region
6.1.1 APAC Mesalazine Sales by Region (2016-2021)
6.1.2 APAC Mesalazine Revenue by Region (2016-2021)
6.2 APAC Mesalazine Sales by Type
6.3 APAC Mesalazine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Mesalazine by Country
7.1.1 Europe Mesalazine Sales by Country (2016-2021)
7.1.2 Europe Mesalazine Revenue by Country (2016-2021)
7.2 Europe Mesalazine Sales by Type
7.3 Europe Mesalazine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Mesalazine by Country
8.1.1 Middle East & Africa Mesalazine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Mesalazine Revenue by Country (2016-2021)
8.2 Middle East & Africa Mesalazine Sales by Type
8.3 Middle East & Africa Mesalazine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Mesalazine Distributors
10.3 Mesalazine Customer
11 Global Mesalazine Market Forecast
11.1 Global Mesalazine Forecast by Region
11.1.1 Global Mesalazine Forecast by Regions (2021-2026)
11.2.2 Global Mesalazine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Mesalazine Forecast by Type
11.7 Global Mesalazine Forecast by Application
12 Key Players Analysis
12.1 Syntese A/S
12.1.1 Syntese A/S Syntese A/S Company Information
12.1.2 Syntese A/S Mesalazine Product Offered
12.1.3 Syntese A/S Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Syntese A/S Main Business Overview
12.1.5 Syntese A/S Latest Developments
12.2 Divis Laboratories
12.2.1 Divis Laboratories Company Information
12.2.2 Divis Laboratories Mesalazine Product Offered
12.2.3 Divis Laboratories Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Divis Laboratories Main Business Overview
12.2.5 Divis Laboratories Latest Developments
12.3 Cambrex Corporation
12.3.1 Cambrex Corporation Company Information
12.3.2 Cambrex Corporation Mesalazine Product Offered
12.3.3 Cambrex Corporation Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Cambrex Corporation Main Business Overview
12.3.5 Cambrex Corporation Latest Developments
12.4 Ipca Laboratories
12.4.1 Ipca Laboratories Company Information
12.4.2 Ipca Laboratories Mesalazine Product Offered
12.4.3 Ipca Laboratories Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Ipca Laboratories Main Business Overview
12.4.5 Ipca Laboratories Latest Developments
12.5 PharmaZell
12.5.1 PharmaZell Company Information
12.5.2 PharmaZell Mesalazine Product Offered
12.5.3 PharmaZell Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 PharmaZell Main Business Overview
12.5.5 PharmaZell Latest Developments
12.6 Lasa Loboratory
12.6.1 Lasa Loboratory Company Information
12.6.2 Lasa Loboratory Mesalazine Product Offered
12.6.3 Lasa Loboratory Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Lasa Loboratory Main Business Overview
12.6.5 Lasa Loboratory Latest Developments
12.7 Erregierre SpA
12.7.1 Erregierre SpA Company Information
12.7.2 Erregierre SpA Mesalazine Product Offered
12.7.3 Erregierre SpA Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Erregierre SpA Main Business Overview
12.7.5 Erregierre SpA Latest Developments
12.8 Corden Pharma Bergamo
12.8.1 Corden Pharma Bergamo Company Information
12.8.2 Corden Pharma Bergamo Mesalazine Product Offered
12.8.3 Corden Pharma Bergamo Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Corden Pharma Bergamo Main Business Overview
12.8.5 Corden Pharma Bergamo Latest Developments
12.9 CTX Lifescience
12.9.1 CTX Lifescience Company Information
12.9.2 CTX Lifescience Mesalazine Product Offered
12.9.3 CTX Lifescience Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 CTX Lifescience Main Business Overview
12.9.5 CTX Lifescience Latest Developments
12.10 Ishita Active Pharma Ingredients
12.10.1 Ishita Active Pharma Ingredients Company Information
12.10.2 Ishita Active Pharma Ingredients Mesalazine Product Offered
12.10.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Ishita Active Pharma Ingredients Main Business Overview
12.10.5 Ishita Active Pharma Ingredients Latest Developments
12.11 YC Biotech (Jiangsu)
12.11.1 YC Biotech (Jiangsu) Company Information
12.11.2 YC Biotech (Jiangsu) Mesalazine Product Offered
12.11.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 YC Biotech (Jiangsu) Main Business Overview
12.11.5 YC Biotech (Jiangsu) Latest Developments
12.12 Xinxiang Tianfeng Fine Chemical
12.12.1 Xinxiang Tianfeng Fine Chemical Company Information
12.12.2 Xinxiang Tianfeng Fine Chemical Mesalazine Product Offered
12.12.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Xinxiang Tianfeng Fine Chemical Main Business Overview
12.12.5 Xinxiang Tianfeng Fine Chemical Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Mesalazine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Purity ≥ 97 %
Table 3. Major Players of Purity ≥ 98 %
Table 4. Major Players of Purity ≥ 99 %
Table 5. Global Mesalazine Sales by Type (2016-2021) & (Ton)
Table 6. Global Mesalazine Sales Market Share by Type (2016-2021)
Table 7. Global Mesalazine Revenue by Type (2016-2021) & ($ million)
Table 8. Global Mesalazine Revenue Market Share by Type (2016-2021)
Table 9. Global Mesalazine Sale Price by Type (2016-2021)
Table 10. Global Mesalazine Sales by Application (2016-2021) & (Ton)
Table 11. Global Mesalazine Sales Market Share by Application (2016-2021)
Table 12. Global Mesalazine Value by Application (2016-2021)
Table 13. Global Mesalazine Revenue Market Share by Application (2016-2021)
Table 14. Global Mesalazine Sale Price by Application (2016-2021)
Table 15. Global Mesalazine Sales by Company (2019-2021) & (Ton)
Table 16. Global Mesalazine Sales Market Share by Company (2019-2021)
Table 17. Global Mesalazine Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Mesalazine Revenue Market Share by Company (2019-2021)
Table 19. Global Mesalazine Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Mesalazine Producing Area Distribution and Sales Area
Table 21. Players Mesalazine Products Offered
Table 22. Mesalazine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Mesalazine Sales by Region (2016-2021) (Ton)
Table 26. Global Mesalazine Sales Market Share by Region (2016-2021)
Table 27. Global Mesalazine Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Mesalazine Revenue Market Share by Region (2016-2021)
Table 29. Americas Mesalazine Sales by Country (2016-2021) & (Ton)
Table 30. Americas Mesalazine Sales Market Share by Country (2016-2021)
Table 31. Americas Mesalazine Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Mesalazine Revenue Market Share by Country (2016-2021)
Table 33. Americas Mesalazine Sales by Type (2016-2021) & (Ton)
Table 34. Americas Mesalazine Sales Market Share by Type (2016-2021)
Table 35. Americas Mesalazine Sales by Application (2016-2021) & (Ton)
Table 36. Americas Mesalazine Sales Market Share by Application (2016-2021)
Table 37. APAC Mesalazine Sales by Region (2016-2021) & (Ton)
Table 38. APAC Mesalazine Sales Market Share by Region (2016-2021)
Table 39. APAC Mesalazine Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Mesalazine Revenue Market Share by Region (2016-2021)
Table 41. APAC Mesalazine Sales by Type (2016-2021) & (Ton)
Table 42. APAC Mesalazine Sales Market Share by Type (2016-2021)
Table 43. APAC Mesalazine Sales by Application (2016-2021) & (Ton)
Table 44. APAC Mesalazine Sales Market Share by Application (2016-2021)
Table 45. Europe Mesalazine Sales by Country (2016-2021) & (Ton)
Table 46. Europe Mesalazine Sales Market Share by Country (2016-2021)
Table 47. Europe Mesalazine Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Mesalazine Revenue Market Share by Country (2016-2021)
Table 49. Europe Mesalazine Sales by Type (2016-2021) & (Ton)
Table 50. Europe Mesalazine Sales Market Share by Type (2016-2021)
Table 51. Europe Mesalazine Sales by Application (2016-2021) & (Ton)
Table 52. Europe Mesalazine Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Mesalazine Sales by Country (2016-2021) & (Ton)
Table 54. Middle East & Africa Mesalazine Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Mesalazine Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Mesalazine Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Mesalazine Sales by Type (2016-2021) & (Ton)
Table 58. Middle East & Africa Mesalazine Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Mesalazine Sales by Application (2016-2021) & (Ton)
Table 60. Middle East & Africa Mesalazine Sales Market Share by Application (2016-2021)
Table 61. Global Mesalazine Sales Forecast by Type (2021-2026) & (Ton)
Table 62. Global Mesalazine Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Mesalazine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Mesalazine Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Mesalazine Sales Forecast by Application (2021-2026) & (Ton)
Table 66. Global Mesalazine Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Mesalazine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Mesalazine Revenue Market Share Forecast by Application (2021-2026)
Table 69. Syntese A/S Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 70. Syntese A/S Mesalazine Product Offered
Table 71. Syntese A/S Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 72. Syntese A/S Main Business
Table 73. Syntese A/S Latest Developments
Table 74. Divis Laboratories Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 75. Divis Laboratories Mesalazine Product Offered
Table 76. Divis Laboratories Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 77. Divis Laboratories Main Business
Table 78. Divis Laboratories Latest Developments
Table 79. Cambrex Corporation Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 80. Cambrex Corporation Mesalazine Product Offered
Table 81. Cambrex Corporation Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 82. Cambrex Corporation Main Business
Table 83. Cambrex Corporation Latest Developments
Table 84. Ipca Laboratories Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 85. Ipca Laboratories Mesalazine Product Offered
Table 86. Ipca Laboratories Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 87. Ipca Laboratories Main Business
Table 88. Ipca Laboratories Latest Developments
Table 89. PharmaZell Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 90. PharmaZell Mesalazine Product Offered
Table 91. PharmaZell Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 92. PharmaZell Main Business
Table 93. PharmaZell Latest Developments
Table 94. Lasa Loboratory Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 95. Lasa Loboratory Mesalazine Product Offered
Table 96. Lasa Loboratory Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 97. Lasa Loboratory Main Business
Table 98. Lasa Loboratory Latest Developments
Table 99. Erregierre SpA Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 100. Erregierre SpA Mesalazine Product Offered
Table 101. Erregierre SpA Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 102. Erregierre SpA Main Business
Table 103. Erregierre SpA Latest Developments
Table 104. Corden Pharma Bergamo Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 105. Corden Pharma Bergamo Mesalazine Product Offered
Table 106. Corden Pharma Bergamo Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 107. Corden Pharma Bergamo Main Business
Table 108. Corden Pharma Bergamo Latest Developments
Table 109. CTX Lifescience Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 110. CTX Lifescience Mesalazine Product Offered
Table 111. CTX Lifescience Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 112. CTX Lifescience Main Business
Table 113. CTX Lifescience Latest Developments
Table 114. Ishita Active Pharma Ingredients Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 115. Ishita Active Pharma Ingredients Mesalazine Product Offered
Table 116. Ishita Active Pharma Ingredients Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 117. Ishita Active Pharma Ingredients Main Business
Table 118. Ishita Active Pharma Ingredients Latest Developments
Table 119. YC Biotech (Jiangsu) Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 120. YC Biotech (Jiangsu) Mesalazine Product Offered
Table 121. YC Biotech (Jiangsu) Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 122. YC Biotech (Jiangsu) Main Business
Table 123. YC Biotech (Jiangsu) Latest Developments
Table 124. Xinxiang Tianfeng Fine Chemical Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 125. Xinxiang Tianfeng Fine Chemical Mesalazine Product Offered
Table 126. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 127. Xinxiang Tianfeng Fine Chemical Main Business
Table 128. Xinxiang Tianfeng Fine Chemical Latest Developments
List of Figures
Figure 1. Picture of Mesalazine
Figure 2. Mesalazine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesalazine Sales Growth Rate 2016-2026 (Ton)
Figure 7. Global Mesalazine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Mesalazine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Purity ≥ 97 %
Figure 10. Product Picture of Purity ≥ 98 %
Figure 11. Product Picture of Purity ≥ 99 %
Figure 12. Global Mesalazine Sales Market Share by Type in 2020
Figure 13. Global Mesalazine Revenue Market Share by Type (2016-2021)
Figure 14. Mesalazine Consumed in Mesalazine Tablets
Figure 15. Global Mesalazine Market: Mesalazine Tablets (2016-2021) & (Ton)
Figure 16. Mesalazine Consumed in Mesalazine Capsules
Figure 17. Global Mesalazine Market: Mesalazine Capsules (2016-2021) & (Ton)
Figure 18. Mesalazine Consumed in Others
Figure 19. Global Mesalazine Market: Others (2016-2021) & (Ton)
Figure 20. Global Mesalazine Sales Market Share by Application (2016-2021)
Figure 21. Global Mesalazine Revenue Market Share by Application in 2020
Figure 22. Global Mesalazine Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Mesalazine Revenue Market Share by Company in 2020
Figure 24. Global Mesalazine Sales Market Share by Regions (2016-2021)
Figure 25. Global Mesalazine Revenue Market Share by Region in 2020
Figure 26. Americas Mesalazine Sales 2016-2021 (Ton)
Figure 27. Americas Mesalazine Revenue 2016-2021 ($ Millions)
Figure 28. APAC Mesalazine Sales 2016-2021 (Ton)
Figure 29. APAC Mesalazine Revenue 2016-2021 ($ Millions)
Figure 30. Europe Mesalazine Sales 2016-2021 (Ton)
Figure 31. Europe Mesalazine Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Mesalazine Sales 2016-2021 (Ton)
Figure 33. Middle East & Africa Mesalazine Revenue 2016-2021 ($ Millions)
Figure 34. Americas Mesalazine Sales Market Share by Country in 2020
Figure 35. Americas Mesalazine Revenue Market Share by Country in 2020
Figure 36. Americas Mesalazine Sales Market Share by Type in 2020
Figure 37. Americas Mesalazine Sales Market Share by Application in 2020
Figure 38. United States Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Mesalazine Sales Market Share by Region in 2020
Figure 43. APAC Mesalazine Revenue Market Share by Regions in 2020
Figure 44. APAC Mesalazine Sales Market Share by Type in 2020
Figure 45. APAC Mesalazine Sales Market Share by Application in 2020
Figure 46. China Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Mesalazine Sales Market Share by Country in 2020
Figure 53. Europe Mesalazine Revenue Market Share by Country in 2020
Figure 54. Europe Mesalazine Sales Market Share by Type in 2020
Figure 55. Europe Mesalazine Sales Market Share by Application in 2020
Figure 56. Germany Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Mesalazine Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Mesalazine Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Mesalazine Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Mesalazine Sales Market Share by Application in 2020
Figure 65. Egypt Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles